Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 30.85
+0.10 (0.33%)
Sep 3, 2025, 10:40 AM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 3.07 billion as of September 2, 2025. Its market cap has increased by 6.40% in one year.
Market Cap
3.07B
Enterprise Value
2.51B
Revenue
2.03B
Ranking
n/a
PE Ratio
19.11
Stock Price
30.85
Market Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.07B, an increase of 115.68%. That is a compound annual growth rate of 3.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 3.07B | 2.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | 2.35B | -16.91% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 359.06B |
| PharmaEssentia | 170.30B |
| Bora Pharmaceuticals Co., LTD. | 88.98B |
| Lotus Pharmaceutical | 50.76B |
| Lumosa Therapeutics | 37.82B |
| Oneness Biotech | 37.54B |
| Polaris Group | 29.16B |
| Center Laboratories | 28.56B |